Global cancer burden growing, amidst mounting need for services
On Feb. 1, 2024, the World Health Organization (WHO) announced that new estimates on IARCﾒs Global Cancer Observatory…
-
-
HPV vaccine study found zero cases of cervical cancer among women vaccinated before age 14
On Jan. 25, 2024, an historic study out of Scotland showed the real-world impact of vaccines against the…
-
Health effects associated with exposure to secondhand smoke: a Burden of Proof study
On Jan. 9, 2024, the Institute for Health Metrics and Evaluation (HHMI) reported that despite a gradual decline…
-
Molecular jackhammers’ ‘good vibrations’ eradicate cancer cells
On Dec. 19, 2023, a research team led by Rice University reported they found that the atoms of…
-
W. Kimryn Rathmell, M.D., Ph.D., began work as 17th director of the National Cancer Institute
On Dec. 18, 2023, W. Kimryn Rathmell, M.D., Ph.D., began work as the 17th director of the National…
-
Pfizer completed acquisition of Seagen for $43 billion
On Dec. 14, 2023, Pfizer announced it had completed the acquisition of Seagen, a global biotechnology company based…
-
Biotechnology | Diagnostics | Disease | Genomics | Neurology | Therapeutics
Alberta researchers revealed full structure of ‘ancient genetic parasite’ implicated in human diseases
On Dec. 14, 2023, the University of Alberta announced that a study published in Nature sheds light on…
-
Using next-gen CRISPR tool, Gladstone scientists created unprecedented molecular map of human immune response
On Dec. 13, 2023, in a study of historic scale, scientists at Gladstone Institutes announced that they had…
-
University of Missouri research reactor announced commercial shipments of radioisotope for cancer treatment
On Dec. 6, 2023, the University of Missouri Research Reactor (MURR) announced they had completed its first commercial…
-
Biotechnology | Diagnostics | Disease | Genomics | Neurology | Oncology | Therapeutics
World’s largest genetic project unveiled incredible new data
On Nov. 30, 2023, in a momentous landmark for medical research, UK Biobank announced that it had unveiled…
-
FDA approved first therapy for rare type of non-cancerous tumorsﾠ
On Nov. 27, 2023, the U.S. Food and Drug Administration approved SpringWorks’ Ogsiveo (nirogacestat) tablets for adult patients…
-
CPRIT invested $63 million to bring innovative researchers and companies to Texas
On Nov. 15, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
-
NIH unveiled comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries
On Aug. 14, 2023, the National Institute of Health announced that it had released a comprehensive dataset that…
-
Henrietta Lacks’ family settled lawsuit with biotech company that used her cells without consent
On Aug. 1, 2023, more than 70 years after doctors at Johns Hopkins Hospital took Henrietta Lacks’ cervical…
-
Biotechnology | FDA | Oncology | Radiology | Stem Cell
U.S. FDA approves cell therapy for patients with blood cancers to reduce risk of infection after stem cell transplantation
On Apr. 17, 2023, the U.S. Food and Drug Administration (FDA) approved Gamida Cell’s Omisirge (omidubicel-onlv), a substantially…
-
Biotechnology | Diagnostics | Medicine | NIH | Oncology | Radiology | Therapeutics | Women's Health
U.S. Department of Health and Human Services released National Cancer Plan
On Apr. 3, 2023, the U.S. Department of Health and Human Services (HHS) released a National Cancer Plan,…
-
Thermo Fisher Scientific opened cell therapy facility at University of California, San Francisco
On Mar. 27. 2023, Thermo Fisher Scientific and the University of California, San Francisco, announced they will accelerate…
-
Biotechnology | Diagnostics | NIH | Oncology | Radiology
Blood test identified acute myeloid leukemia patients at greater risk for relapse after bone marrow transplant
On Mar. 7, 2023, researchers at the National Institutes of Health reported the benefits of screening adult patients…
-
Veklury (Remdesivir) reduced risk of mortality in hospitalized COVID-19 patients across all variants in real world study
On Feb. 21, 2023, Gilead Sciences announced positive data from three retrospective real-world studies which demonstrated that initiation…
-
CPRIT approved $12 million to bring top-flight cancer researchers to Lone Star State
On Feb. 15, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced a major step forward…
-
University of Wisconsin and TGen researchers used machine learning to make early detection of cancerm more accessible
On Jan. 13, 2023, a team of researchers including faculty at the Translational Genomics Research Institute (TGen), part…
-
Purdue Center for Cancer Research renamed Purdue Institute for Cancer Research
On Jan. 6, 2023, the Purdue Center for Cancer Research announced it was changing its name to the…
-
BioNTech announced strategic partnership with UK Government to provide up to 10,000 patients with personalized mRNA cancer immunotherapies
On Jan. 5, 2023, BioNTech announced that the Company had signed a Memorandum of Understanding with the Government…
-
FDA approved first gene therapy for treatment of high-risk, non-muscle-invasive bladder cancer
On Dec. 16, 2022, the U.S. Food and Drug Administration approved Ferring Pharmaceuticals’ Adstiladrin (nadofaragene firadenovec-vncg), a non-replicating…
-
Biotechnology | FDA | Oncology | Therapeutics
FDA granted approval to atezolizumab for alveolar soft part sarcoma
On Dec. 9, 2022, the U.S. Food and Drug Administration (FDA) approved Genentech’s atezolizumab (Tecentriq) for adult and…
-
U.S. launched largest ever liver cancer screening study VA launched largest ever liver cancer screening study
On Dec. 8, 2022, the Department of Veterans Affairs embarked on a study to determine the most effective…
-
Biotechnology | Diagnostics | Non-Profit Research | Oncology | Therapeutics | Vaccine | Women's Health
CPRIT approved $12 million to bring top-flight cancer researchers to Lone Star State
On Nov. 16, 2022, the Cancer Prevention and Research Institute of Texas (CPRIT) approved $12 million in recruitment…
-
Fred Hutchinson Cancer Center received $78 million gift to support precision oncology
On Sept. 8, 2022, the Fred Hutchinson Cancer Center (FHCRC) announced that Stuart and Molly Sloan had pledged…
-
Patient with HIV achieved remission following stem cell transplant
On Jul. 27, 2022, City of Hope announced that a 66-year-old man who was diagnosed with HIV in…
-
Wake Forest CCSG cut from 5 years to 3 as center changes leadership, administrative structure
May 27, 2022, the National Cancer Institute (NCI) truncated the just-renewed five-year Cancer Center Support Grant held by…
